Alignment Healthcare (NASDAQ:ALHC) Reaches New 52-Week High – What’s Next?

Alignment Healthcare, Inc. (NASDAQ:ALHC)’s share price reached a new 52-week high on Monday . The company traded as high as $21.08 and last traded at $21.0760, with a volume of 1794389 shares traded. The stock had previously closed at $20.22.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on ALHC shares. Wall Street Zen raised shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. Barclays lifted their price objective on shares of Alignment Healthcare from $13.00 to $18.00 and gave the company an “equal weight” rating in a research note on Friday, October 31st. The Goldman Sachs Group reaffirmed a “buy” rating and set a $22.00 price target on shares of Alignment Healthcare in a report on Monday, November 3rd. UBS Group lifted their price objective on Alignment Healthcare from $17.00 to $18.00 and gave the company a “neutral” rating in a report on Friday, October 31st. Finally, KeyCorp reaffirmed an “overweight” rating on shares of Alignment Healthcare in a research note on Monday, November 24th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $20.35.

Alignment Healthcare Stock Up 3.9%

The firm has a market capitalization of $4.20 billion, a PE ratio of -175.00, a price-to-earnings-growth ratio of 5.81 and a beta of 1.16. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.99. The firm has a 50-day moving average of $18.37 and a two-hundred day moving average of $16.33.

Alignment Healthcare (NASDAQ:ALHC) last issued its earnings results on Thursday, October 30th. The company reported $0.02 EPS for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.03. The business had revenue of $993.70 million for the quarter, compared to the consensus estimate of $980.90 million. Alignment Healthcare had a negative net margin of 0.57% and a negative return on equity of 16.23%. The business’s revenue for the quarter was up 43.5% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.14) EPS. On average, equities research analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Insider Buying and Selling at Alignment Healthcare

In other news, Director Joseph S. Konowiecki sold 25,000 shares of Alignment Healthcare stock in a transaction that occurred on Tuesday, October 28th. The stock was sold at an average price of $18.00, for a total value of $450,000.00. Following the completion of the transaction, the director owned 1,085,973 shares in the company, valued at approximately $19,547,514. This trade represents a 2.25% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Dawn Christine Maroney sold 282,070 shares of the business’s stock in a transaction dated Monday, December 29th. The shares were sold at an average price of $18.74, for a total transaction of $5,285,991.80. Following the sale, the president directly owned 1,385,167 shares of the company’s stock, valued at approximately $25,958,029.58. This represents a 16.92% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 1,828,297 shares of company stock valued at $33,667,738. Corporate insiders own 6.60% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of ALHC. Larson Financial Group LLC bought a new position in Alignment Healthcare during the third quarter valued at about $33,000. GAMMA Investing LLC lifted its stake in shares of Alignment Healthcare by 83.8% in the 4th quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock valued at $43,000 after purchasing an additional 987 shares during the period. Wilmington Savings Fund Society FSB bought a new position in Alignment Healthcare during the 3rd quarter worth approximately $53,000. SBI Securities Co. Ltd. raised its stake in Alignment Healthcare by 4,868.9% during the 2nd quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock worth $42,000 after buying an additional 2,970 shares during the period. Finally, KBC Group NV bought a new position in Alignment Healthcare in the second quarter valued at approximately $44,000. 86.19% of the stock is owned by institutional investors and hedge funds.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.